Market Closed -
Other stock markets
|
Pre-market 09:27:45 am | |||
64.96 USD | -0.02% | 64.98 | +0.02% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 142
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Protein-based Immunotherapies
100.0
%
| 30 | 100.0 % | 59 | 100.0 % | +95.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 30 | 100.0 % | 59 | 100.0 % | +95.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
Director of Finance/CFO | - | 17-05-31 | |
Stanford Peng
PSD | President | 53 | 17-07-23 |
James Rickey
DFI | Director of Finance/CFO | 45 | 17-07-23 |
Christina Yi
CTO | Chief Tech/Sci/R&D Officer | 48 | 23-08-20 |
Wolfgang Dummer
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-10-01 |
Temre Johnson
IRC | Investor Relations Contact | - | - |
Remy Durand
PRN | Corporate Officer/Principal | 38 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 17-06-30 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Topper
BRD | Director/Board Member | 62 | 16-05-31 |
Peter Thompson
BRD | Director/Board Member | 64 | 16-05-31 |
Natasha Hernday
BRD | Director/Board Member | 52 | 20-12-09 |
Director/Board Member | 45 | 18-04-23 | |
Xiang Ming Cui
BRD | Director/Board Member | 55 | 19-01-17 |
Jörn Drappa
BRD | Director/Board Member | 60 | 22-07-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,597,527 | 65,407,700 ( 95.35 %) | 0 | 95.35 % |
Company contact information
Alpine Immune Sciences, Inc.
188 East Blaine Street Suite 200
98102, Seattle
+
http://www.alpineimmunesciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.82% | 4.46B | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.38% | 22.28B | |
-5.48% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ALPN Stock
- Company Alpine Immune Sciences, Inc.